
Numinus Wellness
Company that markets psychedelic psychotherapy for mental health problems.
Market cap
$11.8m
Enterprise value
$14m
Share price
CAD0.05 NUMI.TO
Recent deals
Get premium to view all results
Date | Investors | Amount | Round |
---|---|---|---|
investor | €0.0 | round | |
N/A | €0.0 | round | |
N/A | €0.0 | round | |
* | CAD6.0m | Post IPO Equity | |
Total Funding | 000k |
CAD | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Revenues | 0000 | 0000 | 0000 | 0000 | 0000 |
% growth | - | 720 % | 72 % | 329 % | 257 % |
EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 |
% EBITDA margin | (6212 %) | (748 %) | (1001 %) | (408 %) | (106 %) |
Profit | 0000 | 0000 | 0000 | 0000 | 0000 |
% profit margin | (6762 %) | (1090 %) | (1240 %) | (691 %) | (131 %) |
EV | 0000 | 0000 | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 |
R&D % of revenue | 138 % | 21 % | 93 % | 29 % | 5 % |
Source: Company filings or news article
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by Numinus Wellness
Edit
ACQUISITION by Numinus Wellness Apr 2022

ACQUISITION by Numinus Wellness Jul 2021